Portosinusoidal vascular dis ease with portal hypertension – a case report
Authors:
V. Sentivanová 1; M. Hlavatý 2; O. Fabián 3,4; E. Sticová 3; O. Semerád 1; P. Kohout 1
Authors place of work:
Interní klinika 3. LF UK a Fakultní Thomayerovy nemocnice, Praha
1; Klinika hepatogastroenterologie, Institut klinické a experimentální medicíny, Praha
2; Pracoviště klinické a transplantační patologie, Institut klinické a experimentální medicíny, Praha
3; Ústav patologie a molekulární medicíny 3. LF UK a Fakultní Thomayerovy nemocnice, Praha
4
Published in the journal:
Gastroent Hepatol 2024; 78(5): 417-423
Category:
Kazuistika
doi:
https://doi.org/10.48095/ccgh2024417
Summary
Portosinusoidal vascular disease (PSVD) is a rarely recognized liver condition caused by the involvement of small hepatic vessels. The diagnosis is established based on a set of clinical and/or histopathological criteria, with the absolute requirement of excluding liver cirrhosis through biopsy. Clinically, PSVD often presents with complications related to portal hypertension, although not all patients exhibit these signs. This article discusses the case of a 71-year-old patient with known splenomegaly, which had not been fully investigated and lacked a hematological explanation. The patient was evaluated for severe symptomatic microcytic anemia, likely secondary to portal hypertension, despite the absence of overt bleeding symptoms. During hospitalization, ligation of large, high-risk esophageal varices was performed, and no other sources of anemia were identified. Pre- or post-hepatic causes of portal hypertension were ruled out. Liver elastography results were within normal ranges, and liver function tests were normal except for a marginal isolated elevation of gamma-glutamyltransferase. Liver function remained intact. Liver biopsy findings were consistent with a diagnosis of PSVD. The patient did not have any identifiable associated conditions and was not taking any medications known to pose a risk. Therefore, treatment was focused solely on managing the complications of portal hypertension. Outpatient follow-up included the eradication of esophageal varices. Treatment with oral iron supplements led to the normalization of hemoglobin levels, which remained stable for months after the discontinuation of therapy, and liver function tests continued to be normal.
Keywords:
porto-sinusoidal vascular disease – portal hypertension – idiopathic non-cirrhotic portal hypertension – hypochromic anemia
Zdroje
Štítky
Dětská gastroenterologie Gastroenterologie a hepatologie Chirurgie všeobecnáČlánek vyšel v časopise
Gastroenterologie a hepatologie

2024 Číslo 5
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- MUDr. Lenka Klimešová: Multioborová vizita může být klíčem k efektivnější perioperační léčbě chronické bolesti
- Horní limit denní dávky vitaminu D: Jaké množství je ještě bezpečné?
- Realita léčby bolesti v paliativní péči v Německu
Nejčtenější v tomto čísle
- Screening kolorektálního karcinomu v České republice – minulost, současnost a budoucnost
- Portosinusoidální vaskulární choroba s portální hypertenzí – popis případu
- Hepatitida E: co potřebujeme vědět o tomto onemocnění?
- Idiopatické střevní záněty a autoimunitní pankreatitida